Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$6.27B
sum of reported positions
Reported positions
833
Changes vs prior quarter
994
141 new · 267 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 299 measured positions in 6 quarters, the typical new or larger position finished −3.3 pts against the S&P 500 and 39% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 1.05M | $146M | 2.3% | |
| 333K | $83.8M | 1.3% | |
| 223K | $76.6M | 1.2% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $6.73B | $6.27B |
| Positions | 959 | 833 |
| Biggest line | — | Intel 2% |
| 957K |
| $74.9M |
| 1.2% |
| 403K | $73M | 1.2% |
| 696K | $71.2M | 1.1% |
| 76K | $70.7M | 1.1% |
| 176K | $69.9M | 1.1% |
| 514K | $69.6M | 1.1% |
| 922K | $68.6M | 1.1% |
| 1.66M | $68.6M | 1.1% |
| 65K | $68.2M | 1.1% |
| 396K | $66.5M | 1.1% |
| 680K | $65.3M | 1.0% |
| 236K | $65.1M | 1.0% |
| 409K | $62M | 1.0% |
| 660K | $60.5M | 1.0% |
| 571K | $59.1M | 0.9% |
| 151K | $54.8M | 0.9% |
| 849K | $54.5M | 0.9% |
| 185K | $54.3M | 0.9% |
| 1.57M | $50.2M | 0.8% |
| 642K | $49.9M | 0.8% |
| 176K | $49.9M | 0.8% |
| 268K | $48.2M | 0.8% |
ServisFirst Bancshares, Inc. (SFBS)
14K shares in Q1 2026
Customers Bancorp, Inc. (CUBI)
14K shares in Q1 2026
Ardelyx (ARDX)
14K shares in Q1 2026
Constellation Energy (CEG)
14K shares in Q1 2026
Senseonics Holdings (SENS)
14K shares in Q1 2026
Balchem Corporation (BCPC)
14K shares in Q1 2026
Fabrinet (FN)
14K shares in Q1 2026
Xometry (XMTR)
13K shares in Q1 2026
Covenant Logistics Group (CVLG)
13K shares in Q1 2026
Avis Budget Group (CAR)
13K shares in Q1 2026
Atrium Therapeutics (RNA)
13K shares in Q1 2026
Crane (CR)
13K shares in Q1 2026
WesBanco (WSBC)
13K shares in Q1 2026
Emcor (EME)
13K shares in Q1 2026
Perspective Therapeutics (CATX)
13K shares in Q1 2026
Stem (STEM)
12K shares in Q1 2026
FIDELIS INSURANCE HOLDINGS L
11K shares in Q1 2026
Oric Pharmaceuticals (ORIC)
11K shares in Q1 2026
RBC Bearings (RBC)
11K shares in Q1 2026
Jfrog (FROG)
11K shares in Q1 2026
Pathward Financial, Inc. (CASH)
11K shares in Q1 2026
Agnico Eagle Mines (AEM)
10K shares in Q1 2026
First Mid Bancshares (FMBH)
10K shares in Q1 2026
ITT Inc. (ITT)
9,931 shares in Q1 2026
Silicon Labs (SLAB)
9,499 shares in Q1 2026
